Onconetix Inc. raised $2 million through a PIPE financing by selling 3,499 shares of Series C convertible preferred stock and warrants to institutional investors, with a registration rights agreement for future resale of common stock. Additionally, the company entered a $25 million equity line of credit agreement allowing it to sell shares of common stock over time.